Cargando…

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress

Multiple mutations of surfactant genes causing surfactant dysfunction have been described. Surfactant protein C (SP-C) deficiency is associated with variable clinical manifestations ranging from neonatal respiratory distress syndrome to lethal lung disease. We present an extremely low birth weight m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarocco, Anna, Ballardini, Elisa, Contiero, Maria Raffaella, Garani, Giampaolo, Fanaro, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426665/ https://www.ncbi.nlm.nih.gov/pubmed/26000190 http://dx.doi.org/10.1155/2015/591783

Ejemplares similares

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
por: Tarocco, Anna, et al.
Publicado: (2015)

Factors affecting yawning frequencies in preterm neonates
por: Menin, Damiano, et al.
Publicado: (2022)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care
por: Tarocco, Anna, et al.
Publicado: (2019)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Diagnostic Challenges in Neonatal Respiratory Distress—Congenital Surfactant Metabolism Dysfunction Caused by ABCA3 Mutation
por: Rogulska, Justyna, et al.
Publicado: (2022)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
por: Mikolajcikova, Silvia, et al.
Publicado: (2022)

Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Correlation between surfactant protein B mRNA expression and neonatal respiratory distress syndrome
por: YIN, XIAOJUAN, et al.
Publicado: (2012)

Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates
por: Sabzevari, Fatemeh, et al.
Publicado: (2023)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease —research or clinical application?
por: Greenough, Anne
Publicado: (1995)

Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates
por: Tsitoura, Maria-Eleni I., et al.
Publicado: (2016)

Outcomes at 7 Years of Age of Former Very Preterm Neonates with Repeated Surfactant Treatment for Prolonged Respiratory Distress in the Neonatal Period
por: Hascoet, Jean-Michel, et al.
Publicado: (2023)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
por: Logan, J Wells, et al.
Publicado: (2009)

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Miao, Jing, et al.
Publicado: (2020)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean Experiences over 17 Years
por: Bae, Chong-Woo, et al.
Publicado: (2009)

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome
por: Xiang, Jiajun, et al.
Publicado: (2019)

Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea
por: Shin, Jeong Eun, et al.
Publicado: (2020)

The effect of high-frequency oscillatory ventilator combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Wang, Tie-Yan, et al.
Publicado: (2022)

Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
por: Goudarzi, Razieh Moazami, et al.
Publicado: (2023)

Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome
por: Somaschini, Marco, et al.
Publicado: (2017)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Efficacy study of pulmonary surfactant combined with assisted ventilation for acute respiratory distress syndrome management of term neonates
por: Liu, Jinfeng, et al.
Publicado: (2017)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
por: Han, Tongyan, et al.
Publicado: (2020)

Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review
por: Magni, Tiziana, et al.
Publicado: (2023)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

ADMINISTRATION OF ANTENATAL GLUCOCORTICOIDS AND POSTNATAL SURFACTANT AMELIORATES RESPIRATORY DISTRESS SYNDROME-ASSOCIATED NEONATAL LETHALITY IN ERK3(−/−) PUPS
por: Guaman, Milenka Cuevas, et al.
Publicado: (2014)

Clinical effects of pulmonary surfactant in combination with nasal continuous positive airway pressure therapy on neonatal respiratory distress syndrome
por: Zhang, Congmin, et al.
Publicado: (2017)

Nebulized versus invasively delivered surfactant therapy for neonatal respiratory distress syndrome: A systematic review and meta-analysis
por: Rong, Hui, et al.
Publicado: (2020)

Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome
por: Walther, Frans J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jq0qagbtoo0c8gm5qeds3sq54d